Agrawal, A., Roué, M., Spitzfaden, C., Petrella, S., Aubry, A., Hann, M., Bax, B. and Mayer, C. (2013). Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motion. Biochemical Journal 456, 263–273, http://doi.org/10.1042/BJ20130538.
Bernard, C., Brossier, F., Sougakoff, W., Veziris, N., Frechet-Jachym, M., Metivier, N., Renvoise, A., Robert, J., Jarlier, V. and On Behalf Of The Mdr-Tb Management Group Of The Nrc, C. (2013). A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union. Euro Surveill 18, URL: http://www.eurosurveillance.org/images/dynamic/EE/V18N33/art20555.pdf.
Bernard, C., Wichlacz, C., Rigoreau, M., Sorhouet, S., Dagiral, R., Jarlier, V. and Veziris, N. (2013). Evaluation of the Fluo-RAL Module for Detection of Tuberculous and Nontuberculous Acid-Fast Bacilli by Fluorescence Microscopy. J Clin Microbiol 51, 3469–3470, http://doi.org/10.1128/JCM.01910-13.
Bouige, A., Darmon, A., Piton, J., Roue, M., Petrella, S., Capton, E., Forterre, P., Aubry, A. and Mayer, C. (2013). Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxes. Biochemical Journal 455, 285–294, http://doi.org/10.1042/BJ20130430.
Bui, T. V., Meyssonnier, V., Boelle, P. Y., Che, D., Antoine, D., Jarlier, V. and Robert, J. (2013). Decrease in the incidence of culture-positive meningitis and cerebral tuberculomas in France from 1990 to 2007. Epidemiol Infect 1–7, http://doi.org/10.1017/S0950268813002276.
Falzon, D., Gandhi, N., Migliori, G. B., Sotgiu, G., Cox, H. S., Holtz, T. H., Hollm-Delgado, M.-G., Keshavjee, S., DeRiemer, K., Centis, R., D’Ambrosio, L., Lange, C. G., Bauer, M. and Menzies, D. (2013). Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J 42, 156–168, http://doi.org/10.1183/09031936.00134712.
Fillion, A., Aubry, A., Brossier, F., Chauffour, A., Jarlier, V. and Veziris, N. (2013). Impact of Fluoroquinolone Resistance on Bactericidal and Sterilizing Activity of a Moxifloxacin-Containing Regimen in Murine Tuberculosis. Antimicrob Agents Chemother 57, 4496–4500, http://doi.org/10.1128/AAC.00506-13.
Fraisse, P. and Veziris, N. (2013). Tuberculose. In: La pneumologie fondée sur des Preuves, Margaud-Orange.
Gomez, C., Ponien, P., Serradji, N., Lamouri, A., Pantel, A., Capton, E., Jarlier, V., Anquetin, G. and Aubry, A. (2013). Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry 21, 948–956, http://doi.org/10.1016/j.bmc.2012.12.011.
Grammatico-Guillon, L., Lanotte, P., Bastides, F., Veziris, N., Bernard, L. and Rosset, P. (2013). Voluminous pseudotumor due to Mycobacterium malmoense. Presse Med 42, 227–230, http://doi.org/10.1016/j.lpm.2012.02.042.
Hillemann, D., Hoffner, S., Cirillo, D., Drobniewski, F., Richter, E., Rüsch-Gerdes, S., Network, the B.-N. T.-L., Pan-Net, T. and Networks, E. E.-T. (2013). First Evaluation after Implementation of a Quality Control System for the Second Line Drug Susceptibility Testing of Mycobacterium tuberculosis Joint Efforts in Low and High Incidence Countries. PLOS ONE 8, e76765, http://doi.org/10.1371/journal.pone.0076765.
Lloret-Linares, C., Mouly, S., Hoang-Nguyen, D.-T., Evans, J., Raskine, L., Lopes, A., Cambau, E., Bergmann, J.-F. and Sellier, P. (2013). Inadequate Therapeutic Response to a Recommended Antituberculosis Fixed-Dose Combination Regimen in an Overweight Patient with Mycobacterium bovis Infection. Ann Pharmacother 47, e4–e4, http://doi.org/10.1345/aph.1R452.
Mechaï, F., Veziris, N., Aoun, O., Bille, E., Lecuit, M., Brossier, F., Viard, J. P. and Lortholary, O. (2013). In vivo selection of a multidrug-resistant Mycobacterium avium isolate in a patient with AIDS. Int J Tuberc Lung Dis 17, 141–142, http://doi.org/10.5588/ijtld.12.0778.
Migliori, G. B., Sotgiu, G., Gandhi, N. R., Falzon, D., DeRiemer, K., Centis, R., Hollm-Delgado, M.-G., Palmero, D., Pérez-Guzmán, C., Vargas, M. H., D’Ambrosio, L., Spanevello, A., Bauer, M., Chan, E. D., Schaaf, H. S., Keshavjee, S., Holtz, T. H., Menzies, D., Mdr-Tb, T. C. G. for M.-A. of I. P. D. in, Ahuja, S., Ashkin, D., Avendano, M., Banerjee, R., Bayona, J. N., Becerra, M. C., Benedetti, A., Burgos, M., Chiang, C.-Y., Cox, H., Dung, N. H., Enarson, D., Flanagan, K., Flood, J., Garcia-Garcia, L., Granich, R. M., Iseman, M. D., Jarlsberg, L. G., Kim, H. R., Koh, W. J., Lancaster, J., Lange, C., Lange, W. C. M. de, Leimane, V., Leung, C. C., Li, J., Mishustin, S. P., Mitnick, C. D., Narita, M., O’Riordan, P., Pai, M., Park, S. K., Pasvol, G., Pena, J., Ponce-de-Leon, A., Quelapio, M. I. D., Riekstina, V., Robert, J., Royce, S., Seung, K. J., Shah, L., Shim, T. S., Shin, S. S., Shiraishi, Y., Sifuentes-Osornio, J., Strand, M. J., Tabarsi, P., Tupasi, T. E., Altena, R. van, Walt, M. V. der, Werf, T. S. V. der, Viiklepp, P., Westenhouse, J., Yew, W. W. and Yim, J. J. (2013). Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J 42, 169–179, http://doi.org/10.1183/09031936.00136312.
Mougari, F., Guglielmetti, L., Lopes, A., Raskine, L. and Cambau, E. (2013). Mycobactérioses non tuberculeuses hors mycobactérioses cutanées. In: Revue Encyclopédie Médico Chirurgicale,.
Pang, S., Renvoisé, A., Perret, C., Guinier, M., Chelghoum, N., Brossier, F., Capton, E., Jarlier, V. and Sougakoff, W. (2013). Whole-Genome Sequence of Mycobacterium abscessus Clinical Strain V06705. Genome Announc 1, e00690-13, http://doi.org/10.1128/genomeA.00690-13.
Radomski, N., Roguet, A., Lucas, F. S., Veyrier, F. J., Cambau, E., Accrombessi, H., Moilleron, R., Behr, M. A. and Moulin, L. (2013). atpE gene as a new useful specific molecular target to quantify Mycobacterium in environmental samples. BMC Microbiology 13, 277, http://doi.org/10.1186/1471-2180-13-277.
Renvoisé, A., Brossier, F., Sougakoff, W., Jarlier, V. and Aubry, A. (2013). Broad-range PCR: Past, present, or future of bacteriology? Médecine et Maladies Infectieuses 43, 322–330, http://doi.org/10.1016/j.medmal.2013.06.003.
Robert, J., Affolabi, D., Awokou, F., Nolna, D., Manouan, B. A. P., Acho, Y. B., Gninafon, M. and Trebucq, A. (2013). Assessment of organizational measures to prevent nosocomial tuberculosis in health facilities of 4 sub-Saharan countries in 2010. Infect Control Hosp Epidemiol 34, 190–195, http://doi.org/10.1086/669085.
Veziris, N. (2013). Les nouveaux antituberculeux (2) : nouvelles molécules. Journal des Anti-infectieux, http://doi.org/10.1016/j.antinf.2013.06.001.
Veziris, N. (2013). Les nouveaux antituberculeux (1) : nouvelles utilisations de molécules existantes. Journal des Anti-infectieux 15, 95–101, http://doi.org/10.1016/j.antinf.2013.03.001.
Veziris, N., Chauffour, A., Escolano, S., Henquet, S., Matsuoka, M., Jarlier, V. and Aubry, A. (2013). Resistance of M. leprae to Quinolones: A Question of Relativity? PLoS Negl Trop Dis 7, e2559, http://doi.org/10.1371/journal.pntd.0002559.